Close
CDMO Safety Testing 2026
Novotech

New Unrivalled Capabilities Take GC-MS to the Next Level of Performance

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Smart Thermal Packaging Enhancing Drug Stability Systems

Maintaining the stability of sensitive pharmaceutical compounds requires more than just standard insulation. Smart thermal packaging integrates advanced temperature control and real-time tracking to create a secure distribution environment. By ensuring that drugs remain within strict thermal parameters throughout their journey, these systems protect the efficacy of medications and enhance the reliability of pharmaceutical distribution networks worldwide.

Real Time Visibility Enhancing Pharma Transport Efficiency

Achieving optimal efficiency in pharmaceutical transport requires an uncompromising focus on transparency. Real-time visibility provides the necessary tools for connected tracking and thermal monitoring, ensuring that drug distribution systems remain secure and effective. By providing continuous oversight of the supply chain, these technologies allow for immediate intervention and data-driven optimization, protecting the integrity of life-saving medications throughout their entire journey.

AI-Driven Cold Chains Transforming Pharma Supply Systems

The integration of artificial intelligence into cold chain management is reshaping the pharmaceutical supply landscape. AI-driven cold chains utilize predictive visibility and intelligent thermal control to optimize logistics operations across global networks. By anticipating risks and automating complex decisions, these systems ensure the integrity of temperature-sensitive medications, significantly enhancing the reliability and efficiency of pharmaceutical distribution on a global scale.
- Advertisement -

Updated with new capabilities in high resolution accurate mass (HRAM) GC-MS, the Thermo Scientific Orbitrap GC-MS systems now give users across metabolomics, food safety, environmental, pharma and toxicology applications high levels of accuracy in their data.

Building on the existing reputation and success of the Thermo Scientific Q Exactive GC Orbitrap and the Exactive GC Orbitrap, enhancements include the addition of Variable electron Voltage (VeV) technology, the Orbitrap GC-MS HRAM Metabolomics Library and the TraceFinder Automated Compound Identification. These new capabilities are designed to provide highly sensitive, selective and accurate compound identification of complex samples for both research and routine laboratories performing gas chromatography mass spectrometry (GC-MS).

“The power of the multi-award winning Orbitrap GC-MS technology has facilitated numerous scientific advances and enabled our customers to break new ground and gain a deeper understanding of samples through the use of HRAM technology,” said Fausto Pigozzo, director of marketing, GC GC-MS, Thermo Fisher. “Our R&D teams are dedicated to advancing this technology and with these newest capabilities offer systems that continue to provide customers with information rich analysis.”

“Orbitrap GC-MS technology provides a remarkable opportunity to explore the metabolome, and alongside other technology is helping us build up an understanding of disease phenotypes in more detail,” said Jean-François Focant, professor and director of the organic and biological analytical chemistry laboratory (OBiAChem), University of Liege, Belgium. “One of the primary challenges in metabolomics is to identify significant metabolites during non-targeted studies. The addition of the new Orbitrap GC-MS HRAM Metabolomics Library is helping us move in the right direction with respect to obtaining putative metabolite identifications quickly, and as such, allowing a fast route to begin the work of understanding the biological meaning of our observations.”

The new capabilities included on the Q Exactive GC Orbitrap and the Exactive GC Orbitrap, include:

  • VeV technology that enables low electron voltage settings to be used during electron ionization (EI) protocols, promoting high mass signals and providing high sensitivity for compounds prone to extensive fragmentation.
  • The Orbitrap HRAM Metabolomics Library for electron ionization (EI), metabolite identification is efficiently streamlined. The library includes more than 800 metabolites and the spectra is refined and curated with the elemental composition of each EI fragment verified.
  • New TraceFinder software features a specialized spectral deconvolution library and automated compound identification to enable identification of challenging compounds. With the addition of Kovats retention index to the scoring index of unknowns, user confidence in compound identification is improved, especially in relation to isomeric compounds.

The Q Exactive GC Orbitrap is a relatively easy-to-use GC-MS system that provides high quality data for compound discovery, identification and quantitation for comprehensive analyses. The Exactive GC Orbitrap GC delivers sensitive, routine grade performance in both targeted and non-targeted screening protocols. Both systems provide excellent resolving power, mass accuracy, linear dynamic range and sensitivity of leading Orbitrap technology.
For more information, please visit www.thermofisher.com/OrbitrapGCMS

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com

World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

Smart Thermal Packaging Enhancing Drug Stability Systems

Maintaining the stability of sensitive pharmaceutical compounds requires more than just standard insulation. Smart thermal packaging integrates advanced temperature control and real-time tracking to create a secure distribution environment. By ensuring that drugs remain within strict thermal parameters throughout their journey, these systems protect the efficacy of medications and enhance the reliability of pharmaceutical distribution networks worldwide.

Real Time Visibility Enhancing Pharma Transport Efficiency

Achieving optimal efficiency in pharmaceutical transport requires an uncompromising focus on transparency. Real-time visibility provides the necessary tools for connected tracking and thermal monitoring, ensuring that drug distribution systems remain secure and effective. By providing continuous oversight of the supply chain, these technologies allow for immediate intervention and data-driven optimization, protecting the integrity of life-saving medications throughout their entire journey.

AI-Driven Cold Chains Transforming Pharma Supply Systems

The integration of artificial intelligence into cold chain management is reshaping the pharmaceutical supply landscape. AI-driven cold chains utilize predictive visibility and intelligent thermal control to optimize logistics operations across global networks. By anticipating risks and automating complex decisions, these systems ensure the integrity of temperature-sensitive medications, significantly enhancing the reliability and efficiency of pharmaceutical distribution on a global scale.

Cold Chain Intelligence Enhancing Pharma Logistics Safety

Global pharmaceutical logistics faces unprecedented challenges in maintaining product integrity during transit. Cold chain intelligence offers a sophisticated solution by integrating predictive monitoring and thermal assurance into a connected supply chain. This approach ensures that life-saving medications and vaccines reach their destination without compromising safety or efficacy, marking a significant evolution in healthcare distribution.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »